Cardiovascular Ultrasound System Market, by End User
- Hospitals/Cardiology Centers
- Ambulatory/Home Care
- Other End Users (Research Institutes, Medical Device and Pharmaceutical Companies)
The market for cardiovascular ultrasound system is expected to grow from USD 1.3 billion in 2016 to USD 1.7 billion by 2021, at a CAGR of 5.4% during the forecast period.
Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures is driving the growth of this market during the forecast period.
By end user, the home care & ambulatory segment is growing at the highest rate.
The home care & ambulatory segment is projected to grow at the highest rate in the market, by end user. The highest growth is due increase in the usage of echocardiographs at the patient’s house itself
Key Market Players
Key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).
Recent Developments:
- In 2015, GE Healthcare signed a memorandum of understanding with the Oregon Health & Science University (U.S.) to undertake collaborative R&D studies in the field of cardiovascular imaging & treatment as well as in big data research
- In 2015, GE Healthcare launched a new 4D cardiac ultrasound software—cSound—for three new ultrasound systems, namely, VividS70, VividE90, and VividE95 in the U.S. and some countries in Europe, Asia, and LatinAmerica.
To Know More @ https://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-system-market-50389652.html
